Standing in the canine precision medicine knowledge gap: Improving annotation of canine cancer genomic biomarkers through systematic comparative analysis of human cancer mutations in COSMIC
Veterinary and Comparative Oncology · 2023
DOI: 10.1111/vco.12911 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary and Comparative Oncology, 2023. Verfasst von Sharadha Sakthikumar und 11 weiteren Autor:innen. Beteiligte Einrichtung: Vidium Animal Health, a TGen Subsidiary, Phoenix, Arizona, USA. Hauptthemen laut MEDLINE: Dog Diseases, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Vidium Animal Health.
Abstract (Originalsprache)
The accrual of cancer mutation data and related functional and clinical associations have revolutionised human oncology, enabling the advancement of precision medicine and biomarker‐guided clinical management. The catalogue of cancer mutations is also growing in canine cancers. However, without direct high‐powered functional data in dogs, it remains challenging to interpret and utilise them in research and clinical settings. It is well‐recognised that canine and human cancers share genetic, molecular and phenotypic similarities. Therefore, leveraging the massive wealth of human mutation data may help advance canine oncology. Here, we present a structured analysis of sequence conservation and conversion of human mutations to the canine genome through a ‘caninisation’ process. We applied this analysis to COSMIC, the Catalogue of Somatic Mutations in Cancer, the most prominent human cancer mutation database. For the project's initial phase, we focused on the subset of the COSMIC data corresponding to Cancer Gene Census (CGC) genes. A total of 670 canine orthologs were found for 721 CGC genes. In these genes, 365 K unique mutations across 160 tumour types were converted successfully to canine coordinates. We identified shared putative cancer‐driving mutations, including pathogenic and hotspot mutations and mutations bearing similar biomarker associations with diagnostic, prognostic and therapeutic utility. Thus, this structured caninisation of human cancer mutations facilitates the interpretation and annotation of canine mutations and helps bridge the knowledge gap to enable canine precision medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vidium Animal Health, a TGen Subsidiary, Phoenix, Arizona, USA.
- Translational Genomics Research Institute, Phoenix, Arizona, USA.
ORCID-Profile: Sharadha Sakthikumar, Salvatore Facista, Derick Whitley, Sara A Byron, Zeeshan Ahmed, Manisha Warrier, Zhanyang Zhu, Esther Chon, Kathryn Banovich, David Haworth, William P D Hendricks, Guannan Wang
Förderung
- Vidium Animal Health
Zitieren
APA
Sakthikumar, S., Facista, S., Whitley, D., Byron, S. A., Ahmed, Z., Warrier, M., Zhu, Z., Chon, E., Banovich, K., Haworth, D., Hendricks, W. P. D., & Wang, G. (2023). Standing in the canine precision medicine knowledge gap: Improving annotation of canine cancer genomic biomarkers through systematic comparative analysis of human cancer mutations in COSMIC. Veterinary and Comparative Oncology. https://doi.org/10.1111/vco.12911
Vancouver
Sakthikumar S, Facista S, Whitley D, Byron SA, Ahmed Z, Warrier M, et al. Standing in the canine precision medicine knowledge gap: Improving annotation of canine cancer genomic biomarkers through systematic comparative analysis of human cancer mutations in COSMIC. Veterinary and Comparative Oncology. 2023. doi:10.1111/vco.12911
BibTeX
@article{Sakthikumar2023,
author = {Sakthikumar, Sharadha and Facista, Salvatore and Whitley, Derick and Byron, Sara A and Ahmed, Zeeshan and Warrier, Manisha and Zhu, Zhanyang and Chon, Esther and Banovich, Kathryn and Haworth, David and Hendricks, William P D and Wang, Guannan},
title = {Standing in the canine precision medicine knowledge gap: Improving annotation of canine cancer genomic biomarkers through systematic comparative analysis of human cancer mutations in COSMIC},
journal = {Veterinary and Comparative Oncology},
year = {2023},
doi = {10.1111/vco.12911}
}
EUVIMED